Listen

News

Sawai Pharmaceutical Receives Approvals for Six Compounds with 13 Strengths of Generic Drugs

Aug. 16. 2018

Osaka, Japan –August 15, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approvals by the Ministry of Health, Labour and Welfare for six compounds with 13 strengths of generic drugs. Among the six compounds, four compounds, Mirtazapine, Atomoxetine Hydrochloride, Tramadol Hydrochloride / Acetaminophen and Capecitabine, are approved for the first time as generics.

* TOARASET® Combination Tablets are Tramadol Hydrochloride and Acetaminophen, and are counted as one compound.
* FREWELL® Combination Tablets are Norethisterone and Ethinylestradiol, and are counted as one compound.

The list of approved products:

1. MIRTAZAPINE OD Tablets 15 mg [SAWAI] / 30 mg [SAWAI], MIRTAZAPINE Tablets 15 mg [SAWAI] / 30 mg [SAWAI]

Generic name Mirtazapine
Indications Depression / depressive state
Brand products REFLEX® TABLETS 15 mg / 30 mg, REMERON® Tablets 15 mg / 30 mg

2. ATOMOXETINE Capsules 5 mg [SAWAI] / 10 mg [SAWAI] / 25 mg [SAWAI] / 40 mg [SAWAI]

Generic name Atomoxetine Hydrochloride
Indications Attention-deficit / hyperactivity disorder (ADHD)
Brand products Strattera® Capsules 5 mg / 10 mg / 25 mg / 40 mg

3. TOARASET® Combination Tablets [SAWAI]

Generic name Tramadol Hydrochloride / Acetaminophen
Indications Non-cancerous chronic pain and pain after tooth extraction that cannot be managed by treatments with non-opioid analgesics
Brand products TRAMCET® Combination Tablets

4. ROPINIROLE Extended-release Tablets 2 mg [SAWAI] / 8 mg [SAWAI]

Generic name Ropinirole Hydrochloride
Indications Parkinson’s disease
Brand products ReQuip® CR Tablets 2 mg / 8 mg

5. FREWELL® Combination Tablets ULD [SAWAI]

Generic name Norethisterone / Ethinylestradiol
Indications Dysmenorrhea
Brand products LUNABELL® Tablets ULD

6. CAPECITABINE Tablets 300 mg [SAWAI]

Generic name Capecitabine
Indications Inoperable or recurrent breast cancer, colorectal cancer, gastric cancer
Brand products XELODA® Tablets 300
Page Top